Additionally, the association between longitudinal changes in TNFR and the subsequent risk of end stage kidney disease or kidney function decline has been reported in studies such as the VA NEPHRON-D trial involving advanced DKD patients and the AASK trial targeting CKD patients with hypertension25. Here, TNFRSF1A is linked to diabetic kidney disease.